Literature DB >> 35918397

Key role of Rho GTPases in motor disorders associated with neurodevelopmental pathologies.

David I Anderson1, Evelyne Bloch-Gallego2.   

Abstract

Growing evidence suggests that Rho GTPases and molecules involved in their signaling pathways play a major role in the development of the central nervous system (CNS). Whole exome sequencing (WES) and de novo examination of mutations, including SNP (Single Nucleotide Polymorphism) in genes coding for the molecules of their signaling cascade, has allowed the recent discovery of dominant autosomic mutations and duplication or deletion of candidates in the field of neurodevelopmental diseases (NDD). Epidemiological studies show that the co-occurrence of several of these neurological pathologies may indeed be the rule. The regulators of Rho GTPases have often been considered for cognitive diseases such as intellectual disability (ID) and autism. But, in a remarkable way, mild to severe motor symptoms are now reported in autism and other cognitive NDD. Although a more abundant litterature reports the involvement of Rho GTPases and signaling partners in cognitive development, molecular investigations on their roles in central nervous system (CNS) development or degenerative CNS pathologies also reveal their role in embryonic and perinatal motor wiring through axon guidance and later in synaptic plasticity. Thus, Rho family small GTPases have been revealed to play a key role in brain functions including learning and memory but their precise role in motor development and associated symptoms in NDD has been poorly scoped so far, despite increasing clinical data highlighting the links between cognition and motor development. Indeed, early impairements in fine or gross motor performance is often an associated feature of NDDs, which then impact social communication, cognition, emotion, and behavior. We review here recent insights derived from clinical developmental neurobiology in the field of Rho GTPases and NDD (autism spectrum related disorder (ASD), ID, schizophrenia, hypotonia, spastic paraplegia, bipolar disorder and dyslexia), with a specific focus on genetic alterations affecting Rho GTPases that are involved in motor circuit development.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35918397     DOI: 10.1038/s41380-022-01702-8

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  106 in total

Review 1.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

Review 2.  Small GTPases in axon outgrowth.

Authors:  L Luo; L Jan; Y N Jan
Journal:  Perspect Dev Neurobiol       Date:  1996

Review 3.  Rho GTPases in collective cell migration.

Authors:  Mirjam M Zegers; Peter Friedl
Journal:  Small GTPases       Date:  2014-05-09

Review 4.  Abnormalities in interactions of Rho GTPases with scaffolding proteins contribute to neurodevelopmental disorders.

Authors:  Alexandra Reichova; Martina Zatkova; Zuzana Bacova; Jan Bakos
Journal:  J Neurosci Res       Date:  2017-11-23       Impact factor: 4.164

5.  Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability.

Authors:  F Chen; L Ma; M C Parrini; X Mao; M Lopez; C Wu; P W Marks; L Davidson; D J Kwiatkowski; T Kirchhausen; S H Orkin; F S Rosen; B J Mayer; M W Kirschner; F W Alt
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 6.  Regulating Rac in the nervous system: molecular function and disease implication of Rac GEFs and GAPs.

Authors:  Yanyang Bai; Xiaoliang Xiang; Chunmei Liang; Lei Shi
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

7.  Coevolution of RAC Small GTPases and their Regulators GEF Proteins.

Authors:  Alejandro Jiménez-Sánchez
Journal:  Evol Bioinform Online       Date:  2016-05-17       Impact factor: 1.625

Review 8.  Revisiting Netrin-1: One Who Guides (Axons).

Authors:  Nicholas P Boyer; Stephanie L Gupton
Journal:  Front Cell Neurosci       Date:  2018-07-31       Impact factor: 5.505

Review 9.  Targeting Rho GTPase Signaling Networks in Cancer.

Authors:  Natasha S Clayton; Anne J Ridley
Journal:  Front Cell Dev Biol       Date:  2020-04-03

10.  Structure of the DOCK2-ELMO1 complex provides insights into regulation of the auto-inhibited state.

Authors:  Matthew J Smith; Jean-Francois Côté; Leifu Chang; Jing Yang; Chang Hwa Jo; Andreas Boland; Ziguo Zhang; Stephen H McLaughlin; Afnan Abu-Thuraia; Ryan C Killoran; David Barford
Journal:  Nat Commun       Date:  2020-07-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.